Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Relief is coming for more than 5 million Medicare beneficiaries who rely on expensive prescription medications.

Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D beneficiaries as drug plans increasingly tie patient costs to list prices, ...

The House Republicans’ budget blueprint, blessed by Speaker Mike Johnson, has long been stalled in the chamber. On Tuesday, Arrington called for a Thursday committee meeting to resolve vast ...

If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these ...

The Centers for Medicare and Medicaid Services (CMS) and pharmaceutical drug manufacturers are gearing up for the second ...

Last year was a pivotal year for the pharmaceutical industry. Under the IRA’s Medicare Drug Price Negotiation Program (the ...

WASHINGTON (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and ...

Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations. As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare ...

The GOP-controlled Senate voted Thursday to confirm Robert F. Kennedy Jr., a longtime anti-vaccine activist, to lead the country’s most powerful health care agency.  Kennedy was confirmed as the ...